Metformin, an Anti-diabetic Drug to Target Leukemia

Frontiers in Endocrinology
Giulia Biondani, Jean-François Peyron

Abstract

Metformin, a widely used anti-diabetic molecule, has attracted a strong interest in the last 10 years as a possible new anti-cancer molecule. Metformin acts by interfering with mitochondrial respiration, leading to an activation of the AMPK tumor-suppressive pathway to promote catabolic-energy saving reactions and block anabolic ones that are associated with abnormal cell proliferation. Metformin also acts at the organism level. In type 2 diabetes patients, metformin reduces hyperglycemia and increases insulin sensitivity by enhancing insulin-stimulated glucose uptake in muscles, liver, and adipose tissue and by reducing glucose output by the liver. Lowering insulin and insulin-like growth factor 1 (IGF-1) levels that stimulate cancer growth could be important features of metformin's mode of action. Despite continuous progress in treatments with the use of targeted therapies and now immunotherapies, acute leukemias are still of very poor prognosis for relapse patients, demonstrating an important need for new treatments deriving from the identification of their pathological supportive mechanisms. In the last decade, it has been realized that if cancer cells modify and reprogram their metabolism to feed their intense biochemical ...Continue Reading

References

Jun 1, 1990·Diabetes Care·A Klip, L A Leiter
Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner
May 1, 1996·Clinical Pharmacokinetics·A J Scheen
Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Aug 22, 2003·Drugs·Ripudaman S Hundal, Silvio E Inzucchi
Feb 24, 1956·Science·O WARBURG
Nov 15, 2003·Current Biology : CB·Angela WoodsDavid Carling
Nov 19, 2003·Life Sciences·Filippo CaraciAlfredo Bianchi
Feb 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Reuben J ShawLewis C Cantley
Apr 2, 2005·Nature Reviews. Cancer·Brian J P Huntly, D Gary Gilliland
Apr 26, 2005·BMJ : British Medical Journal·Josie M M EvansAndrew D Morris
May 4, 2005·Molecular Cell·Russell G JonesCraig B Thompson
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
May 6, 2008·Cell·Leonardo SalmenaPier Paolo Pandolfi
May 10, 2008·Archives of Physiology and Biochemistry·Francesco FrascaRiccardo Vigneri
Aug 30, 2008·The Journal of Clinical Investigation·Arkaitz CarracedoPier Paolo Pandolfi
Sep 9, 2008·Cell·Peggy P Hsu, David M Sabatini
May 1, 2009·The Biochemical Journal·Juan M García-MartínezDario R Alessi
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Jul 25, 2009·Nature Reviews. Cancer·David B Shackelford, Reuben J Shaw
Aug 15, 2009·Expert Opinion on Investigational Drugs·Alberto M MartelliJames A McCubrey
Dec 1, 2009·Current Opinion in Cell Biology·Alejo Efeyan, David M Sabatini
Dec 30, 2009·The Journal of Clinical Investigation·Ismael SamudioMichael Andreeff
Jan 15, 2010·Nature Medicine·Matthew R JanesDavid A Fruman
Mar 17, 2010·The Journal of Biological Chemistry·Kathryn G Foster, Diane C Fingar
May 6, 2010·Molecular Cancer Therapeutics·Issam Ben SahraFrédéric Bost
Jun 18, 2010·CA: a Cancer Journal for Clinicians·Edward GiovannucciDouglas Yee
Jun 26, 2010·The Journal of Clinical Investigation·Russell A Miller, Morris J Birnbaum

❮ Previous
Next ❯

Citations

Feb 16, 2019·Expert Review of Endocrinology & Metabolism·David H AbbottJon E Levine
Jul 26, 2019·BioFactors·Alena PecinováTomáš Mráček
May 21, 2019·Transplantation·Yeqi NianStefan G Tullius
Apr 16, 2020·Pediatric Blood & Cancer·Yordan SbirkovVictoria Sarafian
Sep 8, 2020·Journal of Zhejiang University. Science. B·Shan-Shan SuoJie Jin
Jun 5, 2019·Scientific Reports·Lynnea R WatersMichael A Teitell
Sep 4, 2020·World Journal of Clinical Oncology·Lindsay WildeMargaret Kasner
Sep 3, 2020·International Journal of Molecular Sciences·Laura AnselmiAndrea Pession
Mar 11, 2020·Seminars in Cancer Biology·Vijay P KaleManoj K Pandey
Nov 17, 2020·Frontiers in Endocrinology·Chin-Hsiao Tseng
Apr 23, 2021·Cancer & Metabolism·Svetlana B PaninaNatalia V Kirienko

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
nuclear translocation

Clinical Trials Mentioned

NCT01324180
NCT01750567
NCT03026517
NCT03047837
NCT02581137
NCT01312467
NCT01579812

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Mathilde JalvingElisabeth G E de Vries
Cancer Immunology, Immunotherapy : CII
Sarah SchottChristoph Domschke
Current Opinion in Clinical Nutrition and Metabolic Care
Brennan K Smith, Gregory R Steinberg
© 2022 Meta ULC. All rights reserved